Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL14860953 | 0.94 | ALDH1A1 (0.56) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL168730 | 0.91 | TSHR (0.43) | ALDH1A1TSHRUSP2LMNAHSD17B10 | |
| SCHEMBL2744420 | 0.91 | ALDH1A1 (0.52) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL28374394 | 0.89 | ALDH1A1 (0.50) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Methoxymethane SCHEMBL28184894 | 0.89 | TSHR (0.42) | ALDH1A1TSHRUSP2LMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL28166385 | 0.89 | TSHR (0.42) | ALDH1A1TSHRUSP2LMNAHSD17B10 | |
| SCHEMBL454845 | 0.85 | ALDH1A1 (0.65) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL4942630 | 0.85 | PKM (0.40) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL2786295 | 0.85 | ALDH1A1 (0.39) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL2688076 | 0.85 | GAA (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638965-B | Polyester microparticles, process for producing the same, and injection-filled article | 广东粤港澳大湾区黄埔材料研究院 | 2025-05-13 | — | — | CN | claimed |
| CN-119638965-A | Polyester microparticles, process for producing the same, and injection-filled article | 广东粤港澳大湾区黄埔材料研究院 | 2025-03-18 | — | — | CN | claimed |
| CN-118617824-A | Sound-absorbing cotton with excellent weather resistance for oxygenerator and preparation method thereof | 昆山福瑞达电子包装有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-118530442-A | Polyester microparticle, preparation method thereof and soluble microneedle patch containing polyester microparticle | 广东粤港澳大湾区黄埔材料研究院 | 2024-08-23 | — | — | CN | claimed |
| EP-4285743-A2 | ORAL PRODUCT WITH A BASIC AMINE AND AN ION PAIRING AGENT | Nicoventures Trading Limited (GB) | 2023-12-06 | — | — | EP | claimed |
| CN-116726234-A | Medical adhesive with excellent mechanical properties and preparation method thereof | 北京福爱乐科技发展有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-11013809-B2 | Sustained delivery formulations of risperidone compound | INDIVIOR UK LIMITED (GB) | 2021-05-25 | — | — | US | claimed |
| WO-2018136909-A1 | PREPARATION OF MICROPARTICLES OF AN ACTIVE INGREDIENT | SAVIOR LIFETEC CORPORATION (TW) | 2018-07-26 | — | — | WO | claimed |
| US-20180157440-A1 | INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE | INDIVIOR INC. | 2018-06-07 | — | — | US | claimed |
| CN-105860645-A | Environment-friendly printing ink composition for PVC intaglio | 镇江恒昌塑料彩艺有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-1413270-A | Chemical cleaning solution for gas turbine blades | BIOGENESIS ENTPR INC (US) | 2003-04-23 | — | — | CN | claimed |
| EP-0649662-B1 | Biodegradable implant precursor | ATRIX LAB INC (US) | 2002-02-06 | — | — | EP | claimed |
| US-20020001608-A1 | Biodegradable implant precursor | POLSON ALAN M (US) | 2002-01-03 | — | — | US | claimed |
| EP-1126822-A1 | CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST | ATRIX LABORATORIES, INC. (US) | 2001-08-29 | — | — | EP | claimed |
| US-6143314-A | THERMOPLASTIC RESIN | ATRIX LABORATORIES, INC. (US) | 2000-11-07 | — | — | US | claimed |
| WO-2000024374-A1 | CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST | ATRIX LABORATORIES, INC. (US) | 2000-05-04 | — | — | WO | claimed |
| US-5681873-A | POLYCAPROLACTONE THERMOPLASTIC RESIN | ATRIX LABORATORIES, INC. (US) | 1997-10-28 | — | — | US | claimed |
| WO-1996021427-A1 | LIQUID POLYMER DELIVERY SYSTEM | ATRIX LABORATORIES, INC. (US) | 1996-07-18 | — | — | WO | claimed |
| US-5487897-A | Biodegradable implant precursor | ATRIX LABORATORIES, INC. (US) | 1996-01-30 | — | — | US | claimed |
| EP-0649662-A1 | Biodegradable implant precursor | ATRIX LABORATORIES, INC. (US) | 1995-04-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11013809-B2 | Sustained delivery formulations of risperidone compound | SLC6A3, GRIN2A, GRIN2D | ALDH1A1 1302/4885HMGCR 2093/4885CHRM1 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.